Lymphoma Clinical Trials in Goettigen
2 recruitingGoettigen, Germany
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype
Lymphoma
SecuraBio124 enrolled43 locationsNCT06522737
Recruiting
Phase 2
Study of Lacutamab in Peripheral T-cell Lymphoma
Relapse/RecurrencePeripheral T Cell Lymphoma
The Lymphoma Academic Research Organisation56 enrolled64 locationsNCT04984837